Dose planning study of proton versus photon radiotherapy for head and neck squamous cell carcinoma of unknown primary in the primary and recurrent setting

References

• Overgaard J, Jovanovic A, Godballe C, et al. The Danish head and neck cancer database. Dove Medical Press Ltd; 2016. pp. 491–496. doi: 10.2147/CLEP.S103591.
   Google Scholar
• Johansen LV, Grau C, Overgaard J. Nodal control and surgical salvage after primary radiotherapy in 1782 patients with laryngeal and pharyngeal carcinoma. Acta Oncol. 2004;43(5):486–494. doi: 10.1080/02841860410034289.
   PubMed Web of Science ®Google Scholar
• Grau C, Johansen LV, Jakobsen J, et al. Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish society for head and neck oncology. Radiother Oncol. 2000;55(2):121–129. doi: 10.1016/s0167-8140(00)00172-9.
   PubMed Web of Science ®Google Scholar
• Farooq S, Khandavilli S, Dretzke J, et al. Transoral tongue base mucosectomy for the identification of the primary site in the work-up of cancers of unknown origin: systematic review and meta-analysis. Oral oncology. 2019;91:97–106. doi: 10.1016/j.oraloncology.2019.02.018.
   Google Scholar
• Jakobsen J, Johansen LV, Grau C. National guidelines regarding carcinoma metastasis to the neck from unknown primary tumour. 2013. Available from: www.dahanca.dk
   Google Scholar
• Strojan P, Ferlito A, Langendijk JA, et al. Contemporary management of lymph node metastases from an unknown primary to the neck: II. A review of therapeutic options. Head Neck. 2013;35(2):286–293. doi: 10.1002/hed.21899.
   PubMed Web of Science ®Google Scholar
• LaVigne AW, Margalit DN, Rawal B, et al. IMRT-based treatment of unknown primary malignancy of the head and neck: outcomes and improved toxicity with decreased mucosal dose and larynx sparing. Head Neck. 2019;41(4):959–966. doi: 10.1002/hed.25531.
   PubMed Web of Science ®Google Scholar
• Richards TM, Bhide SA, Miah AB, et al. Total mucosal irradiation with intensity-modulated radiotherapy in patients with head and neck carcinoma of unknown primary: a pooled analysis of two prospective studies. Clin Oncol. 2016;28(9):e77–e84. doi: 10.1016/j.clon.2016.04.035.
   Web of Science ®Google Scholar
• Sher DJ, Balboni TA, Haddad RI, et al. Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck. Int J Radiat Oncol Biol Phys. 2011;80(5):1405–1411. doi: 10.1016/j.ijrobp.2010.04.029.
   PubMed Web of Science ®Google Scholar
• Ghatasheh H, Huang SH, Su J, et al. Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary. Radiother Oncol. 2022;175:56–64. doi: 10.1016/j.radonc.2022.07.016.
   PubMed Web of Science ®Google Scholar
• Straetmans J, Stuut M, Wagemakers S, et al. Tumor control of cervical lymph node metastases of unknown primary origin: the impact of the radiotherapy target volume. Eur Arch Otorhinolaryngol. 2020;277(6):1753–1761. doi: 10.1007/s00405-020-05867-2.
   PubMed Web of Science ®Google Scholar
• Tambas M, Steenbakkers R, van der Laan HP, et al. First experience with model-based selection of head and neck cancer patients for proton therapy. Radiother Oncol. 2020;151:206–213. doi: 10.1016/j.radonc.2020.07.056.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Crijns W, Hussein M, et al. Radiotherapy treatment plannINg study guidelines (RATING): a framework for setting up and reporting on scientific treatment planning studies. Radiother Oncol. 2020;153:67–78. doi: 10.1016/j.radonc.2020.09.033.
   PubMed Web of Science ®Google Scholar
• National RKKP and DAHANCA Guidelines. Radiotherapy guidelines 2020 (National RKKP Guideline). 2020. https://www.dahanca.dk/
   Google Scholar
• Van den Bosch L, van der Schaaf A, van der Laan HP, et al. Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: a new concept for individually optimised treatment. Radiother Oncol. 2021;157:147–154. doi: 10.1016/j.radonc.2021.01.024.
   PubMed Web of Science ®Google Scholar
• Hansen CR, Jensen K, Smulders B, et al. Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35. Radiat Oncol. 2023:109812. doi: 10.1016/j.radonc.2023.109812.
   Google Scholar
• Embring A, Onjukka E, Mercke C, et al. Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection. Radiat Oncol. 2020;15(1):147. doi: 10.1186/s13014-020-01587-3.
   PubMed Web of Science ®Google Scholar